BioNTech (BNTX)
(Delayed Data from NSDQ)
$112.28 USD
-0.23 (-0.20%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $113.13 +0.85 (0.76%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Brokerage Reports
0 items in cart
BioNTech SE Sponsored ADR [BNTX]
Reports for Purchase
Showing records 41 - 60 ( 165 total )
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Revised 2023 Guidance; 2Q23 Financials; Modulating PT to $180
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 8123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 72123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 71123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Vaccine Supply Agreement With European Commission Amended; Modulating PT to $181
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Multiple Datasets Expected at ASCO; 1Q23 Financials; Modulating PT to $198
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 41123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 4123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
COMIRNATY Sales Expected to Significantly Decline in 2023; 4Q22 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
OncoC4 Collaboration; Bivalent Vaccine Gets New EUA; Lowering PT to $210
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 32123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 31123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 3123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 22123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 21123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 2123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 12123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 11123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 1123
Provider: Stock Traders Daily
Analyst: Research Department